Effect of eye NGF administration on two animal models of retinal ganglion cells degeneration.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annali dell'Istituto Superiore di Sanità

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4415/ANN_11_03_08PMID 21952154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes.

  2010cited by this paper
• Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma

  2009cited by this paper
• Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report.

  2009cited by this paper
• Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application.

  2009cited by this paper
• Nerve growth factor as an angiogenic factor.

  2008cited by this paper
• Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma.

  2008cited by this paper
• Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma

  2008cited by this paper
• Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

  2008cited by this paper
• Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

  2007cited by this paper
• Overview of epidemiologic studies of diabetic retinopathy.

  2007cited by this paper
• Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development.

  2006cited by this paper
• Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa.

  2005cited by this paper
• Diabetes mellitus as a Risk Factor for Glaucomatous Optic Neuropathy

  2005cited by this paper
• Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all?

  2005cited by this paper
• Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies.

  2005cited by this paper
• NGF and related molecules in health and disease

  2004cited by this paper
• Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond.

  2003cited by this paper
• Diffusion of high molecular weight compounds through sclera.

  2000cited by this paper
• Vascular Endothelial Growth Factor Has Neurotrophic Activity and Stimulates Axonal Outgrowth, Enhancing Cell Survival and Schwann Cell Proliferation in the Peripheral Nervous System

  1999cited by this paper
• The role of neuronal growth factors in neurodegenerative disorders of the human brain.

  1998cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension

  1997cited by this paper
• A rat model of chronic pressure-induced optic nerve damage.

  1997cited by this paper
• Nerve Growth Factor Prevents Both Neuroretinal Programmed Cell Death and Capillary Pathology in Experimental Diabetes

  1995cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Nerve growth factor reduces apoptosis of axotomized retinal ganglion cells in the neonatal rat.

  1994cited by this paper
• Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia.

  1993cited by this paper
• Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo.

  1993cited by this paper
• Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light.

  1992cited by this paper
• The nerve growth factor family of receptors.

  1992cited by this paper
• Intraocular pressure and glaucoma.

  1989cited by this paper
• Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section

  1989cited by this paper
• The nerve growth factor 35 years later.

  1987cited by this paper
• PURIFICATION OF NERVE GROWTH FACTOR ANTIBODIES BY AFFINITY CHROMATOGRAPHY

  1976cited by this paper
• The nerve growth factor: purification as a 30,000-molecular-weight protein.

  1969cited by this paper

• Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases

  2025cites this paper
• Effects of mesenchymal stromal cells and human recombinant Nerve Growth Factor delivered by bioengineered human corneal lenticule on an innovative model of diabetic retinopathy

  2024cites this paper
• A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia

  2024cites this paper
• Cell and molecular targeted therapies for diabetic retinopathy

  2024cites this paper
• Diabetic Retinopathy: Role of Neurodegeneration and Therapeutic Perspectives.

  2022cites this paper
• The Protective Effects of Neurotrophins and MicroRNA in Diabetic Retinopathy, Nephropathy and Heart Failure via Regulating Endothelial Function

  2022cites this paper
• Roles of growth factors in eye development and ophthalmic diseases.

  2022cites this paper
• NGF Eye Administration Recovers the TrkB and Glutamate/GABA Marker Deficit in the Adult Visual Cortex Following Optic Nerve Crush

  2021cites this paper
• A comparative study on the secretion of various cytokines by pulp stem cells at different passages and their neurogenic potential.

  2021cites this paper
• Influence of Sex on Neuroretinal Degeneration: Six-Month Follow-Up in Rats With Chronic Glaucoma

  2021cites this paper
• NGF and Retinitis Pigmentosa: Structural and Molecular Studies.

  2021cites this paper
• Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021; 165:XX

  2021cites this paper
• Diabetic retinal neurodegeneration as a form of diabetic retinopathy

  2021cites this paper
• Retrobulbar administration of purified anti-nerve growth factor in developing rats induces structural and biochemical changes in the retina and cornea.

  2021cites this paper
• Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration

  2020cites this paper
• Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases

  2020cites this paper
• Nerve growth factor in metabolic complications and Alzheimer's disease: Physiology and therapeutic potential.

  2020cites this paper
• Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach

  2020cites this paper
• Recent Developments for the Treatment of Glaucoma

  2020cites this paper
• Optic Nerve Regeneration: Considerations on Treatment of Acute Optic Neuropathy and End-Stage Disease

  2019cites this paper
• Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet-Rich Plasma: Preliminary Clinical Results

  2019cites this paper
• Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies

  2019cites this paper
• Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results

  2018cites this paper
• Ocular Nerve Growth Factor (NGF) and NGF Eye Drop Application as Paradigms to Investigate NGF Neuroprotective and Reparative Actions.

  2018cites this paper
• Glaucoma - Next Generation Therapeutics: Impossible to Possible

  2018cites this paper
• NGF (SİNİR BÜYÜME FAKTÖRÜ) VE FONKSİYONLARI

  2017cites this paper
• Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress

  2017cites this paper
• Gene therapy for diabetic retinopathy: Are we ready to make the leap from bench to bedside?

  2017cites this paper
• Expression and signaling of NGF in the healthy and injured retina.

  2017cites this paper
• Protective treatments and their target retinal ganglion cells in diabetic retinopathy.

  2017cites this paper
• Nerve growth factor protects against palmitic acid-induced injury in retinal ganglion cells

  2016cites this paper
• Neuroprotection as a Therapeutic Target for Diabetic Retinopathy

  2016cites this paper
• Ultrasound-microbubble enhances bioavailability of neuro growth factor in neuro-retina after intravitreal injection in rabbits

  2016cites this paper
• Neuroprotective Strategies in Glaucoma.

  2016cites this paper
• 2 . Neurodegeneration in DR and the Role of VEGF

  2016cites this paper
• NGF Expression in Reelin-Deprived Retinal Cells: A Potential Neuroprotective Effect

  2015cites this paper
• Expression of growth, trophic and inflammation factors in epiretinal membranes in patients with severe proliferative vitreoretinopathy

  2015cites this paper
• Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure.

  2015cites this paper
• Combination of Bevacizumab and NGF Reduces the Risk of Diabetic Retinopathy

  2015cites this paper
• Imbalance of the Nerve Growth Factor and Its Precursor as a Potential Biomarker for Diabetic Retinopathy

  2015cites this paper
• Silencing p75NTR prevents proNGF-induced endothelial cell death and development of acellular capillaries in rat retina

  2015cites this paper
• Effect of Purified Murine NGF on Isolated Photoreceptors of a Rodent Developing Retinitis Pigmentosa

  2015cites this paper
• Imbalance of the Nerve Growth Factor and Its Precursor: Implication in Diabetic Retinopathy

  2015cites this paper
• NGF and VEGF Effects on Retinal Ganglion Cell Fate: New Evidence from an Animal Model of Diabetes

  2014cites this paper
• Neurotrophin Family Members as Neuroprotectants in Retinal Degenerations

  2014cites this paper
• Neuropeptides, trophic factors, and other substances providing morphofunctional and metabolic protection in experimental models of diabetic retinopathy.

  2014cites this paper
• [Mechanisms of neurotrophic and neuroprotective effects of cerebrolysin in cerebral ischemia].

  2014cites this paper
• Nerve growth factor in diabetic retinopathy: beyond neurons

  2014cites this paper
• Characterization of NGF, trkANGFR, and p75NTR in Retina of Mice Lacking Reelin Glycoprotein

  2014cites this paper
• Neurotrophic factors for retinal ganglion cell neuropathy - with a special reference to diabetic neuropathy in the retina.

  2014cites this paper
• Neurotrophic molecules in the treatment of neurodegenerative disease with focus on the retina: status and perspectives

  2013cites this paper
• Antidiabetic activity of a novel dipeptide mimetic of nerve growth factor

  2013cites this paper
• What can we learn about stroke from retinal ischemia models?

  2012cites this paper
• Biomarkers of Optic Nerve Head Glial Cell Activation Following Biomechanical Insult

  2012cites this paper
• ffects of l-dopa methyl ester on visual cortex injury induced by amblyopia and ts underlying mechanism

  2011cites this paper